394 related articles for article (PubMed ID: 2533557)
1. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
Hjorth S; Sharp T; Hacksell U
Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
[TBL] [Abstract][Full Text] [Related]
2. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Yamada J; Sugimoto Y; Horisaka K
Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
[TBL] [Abstract][Full Text] [Related]
3. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
Hjorth S; Sharp T; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
[TBL] [Abstract][Full Text] [Related]
4. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
Tricklebank MD; Forler C; Fozard JR
Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568
[TBL] [Abstract][Full Text] [Related]
5. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K
Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832
[TBL] [Abstract][Full Text] [Related]
6. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
7. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
Uchitomi Y; Yamawaki S
Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
[TBL] [Abstract][Full Text] [Related]
8. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat.
Przegaliński E; Ismaiel AM; Chojnacka-Wójcik E; Budziszewska B; Tatarczyńska E; Błaszczyńska E
Neuropharmacology; 1990 Jun; 29(6):521-6. PubMed ID: 2143565
[TBL] [Abstract][Full Text] [Related]
9. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
[TBL] [Abstract][Full Text] [Related]
10. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.
Martin P; Beninger RJ; Hamon M; Puech AJ
Behav Brain Res; 1990 May; 38(2):135-44. PubMed ID: 2141988
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
[TBL] [Abstract][Full Text] [Related]
13. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
Mizuta E; Yamaguchi M; Kuno S
Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
[TBL] [Abstract][Full Text] [Related]
14. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
Gradin K; Pettersson A; Hedner T; Persson B
J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997
[TBL] [Abstract][Full Text] [Related]
15. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
[TBL] [Abstract][Full Text] [Related]
17. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
Scott PA; Chou JM; Tang H; Frazer A
J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
[TBL] [Abstract][Full Text] [Related]
18. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
20. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity.
Hillegaart V; Hjorth S
Eur J Pharmacol; 1989 Jan; 160(2):303-7. PubMed ID: 2527161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
